Business Context and Reporting Period
Company: Black Spade Acquisition III Co (BIII)
Reporting Date: January 13, 2026
Event: Consummation of Initial Public Offering (IPO) and Private Placement on January 7, 2026.
The Company is a Cayman Islands-based special purpose acquisition company (SPAC) listed on the New York Stock Exchange. This filing reports the closing of its IPO and the establishment of a trust account for public shareholders.
Key Financial Metrics
| Metric | Value |
|---|---|
| Gross IPO Proceeds | $150,000,000 |
| Units Sold | 17,250,000 (including full over-allotment) |
| Price Per Unit | $10.00 |
| Private Placement Warrants Sold | 8,150,000 |
| Private Placement Proceeds | $4,075,000 ($3.5M to Sponsor, $0.575M to Underwriters) |
| Total Funds in Trust Account | $172,500,000 |
| Trust Composition | $170,663,000 from IPO net proceeds + $1,837,000 from Private Placement |
Note: As this is an IPO filing, traditional operating metrics such as revenue, profit, margins, and debt are not applicable. The filing does not provide a clear value for operating cash flow or liquidity outside of the trust account.
Material Changes
This filing represents the Company's initial public listing. There is no prior comparable period for financial performance comparison. The primary material change is the transition from a private entity to a public company with $172.5 million secured in a trust account.
Outlook, Risks, and Unusual Items
- Capital Structure: Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant. Whole warrants are exercisable at $11.50 per share.
- Trust Account: Funds are held with Continental Stock Transfer & Trust Company for the benefit of public shareholders.
- Financial Statements: An audited balance sheet as of January 7, 2026, is included as Exhibit 99.1.
- Emerging Growth Company: The Company has elected to be treated as an emerging growth company.
Investor Verification Checklist
- Verify the full exercise of the underwriters' over-allotment option (2,250,000 units).
- Confirm the exact allocation of the $172,500,000 trust balance between IPO net proceeds and private placement proceeds.
- Review the audited balance sheet (Exhibit 99.1) for initial working capital and any immediate liabilities.
- Confirm the terms of the Private Placement Warrants sold to the Sponsor versus the Underwriters.